Oragenics Inc.

08/21/2024 | Press release | Distributed by Public on 08/21/2024 06:45

Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients